Molecular dynamic analyses of the interaction of SARS-CoV-1 or 2 variants with various angiotensin-converting enzyme-2 species.

The transmembrane glycoprotein angiotensin-converting enzyme 2 (ACE2) is a key component of the renin-angiotensin system (RAS). It was shown to be the receptor of severe acute respiratory syndrome coronavirus 2 in the COVID-19 outbreak (SARS-COV-2). Furthermore, ACE2 aids in the transport of amino acids across the membrane. ACE2 is lost from the membrane, resulting in soluble ACE2 (sACE2). We aim to examine the structural conformation alterations between SARS-CoV-1 or 2 variants at various periods with ACE2 from various sources, particularly in the area where it interacts with the viral protein and the receptor. It is important to study the molecular dynamics of ACE2/SARS-COV RBD when the structure is available on the database. Here we analyzed the crystal structure of ACE2 from Human, Dog, Mus, Cat, and Bat ACE2 in complex with RBD from SARS-COV-1 and SARS-COV-2. The result shows, there is a variation in the type of residues, number of contact atoms and hydrogen bonds in ACE2 and RBD during the interaction interfaces. By using molecular dynamics simulation, we can measure RMSD, RMSF, SASA, Rg and the difference in the percentage of α helix and β strand. As bat ACE2 & SARS-CoV-2 RBD found to have a high amount of β strand compared to another structure complex, while hACE2 & SARS-CoV-1 RBD has fewer amounts of β strand. Our study provides a deep view of the structure which is available and a summary of many works around ACE2/SARS-CoV RBD interaction.Communicated by Ramaswamy H. Sarma.

[1]  A. Rabaan,et al.  COVID‐19 vaccines and their underbelly: Are we going the right way? , 2023, Health science reports.

[2]  K. Dhama,et al.  The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review , 2023, ChemistrySelect.

[3]  Z. Gai,et al.  Hypertension is still a moving target in the context of COVID‐19 and post‐acute COVID‐19 syndrome , 2022, Journal of medical virology.

[4]  G. Wei,et al.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2 , 2022, Chemical reviews.

[5]  K. Dhama,et al.  Computational studies on potential new anti-Covid-19 agents with a multi-target mode of action , 2022, Journal of King Saud University - Science.

[6]  S. K. Biswal,et al.  SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic , 2022, Chemical biology & drug design.

[7]  Prof Vikas Kumar,et al.  Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain , 2021, Computers in Biology and Medicine.

[8]  M. Abdalla,et al.  Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties , 2021, Computers in Biology and Medicine.

[9]  G. Gao,et al.  The molecular basis for SARS-CoV-2 binding to dog ACE2 , 2021, Nature Communications.

[10]  Xinyi Jiang,et al.  Are the new SARS-CoV-2 variants resistant against the vaccine? , 2021, Human vaccines & immunotherapeutics.

[11]  Xinyi Jiang,et al.  Progress in research on the S protein as the target of COVID-19 vaccines , 2021, Expert review of vaccines.

[12]  G. Gao,et al.  Cross-species recognition of SARS-CoV-2 to bat ACE2 , 2020, Proceedings of the National Academy of Sciences.

[13]  Min Li,et al.  Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 , 2020, Nature Communications.

[14]  G. Gao,et al.  Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2 , 2020, Cell discovery.

[15]  Shuwen Liu,et al.  Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 , 2020, Acta Pharmacologica Sinica.

[16]  Yan Li,et al.  Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy , 2020, Science.

[17]  S. Saber-Samandari,et al.  A Narrative Review of COVID-19: The New Pandemic Disease , 2020, Iranian journal of medical sciences.

[18]  Baoying Huang,et al.  Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2 , 2020, Science.

[19]  K. Yuen,et al.  Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.

[20]  Rohit Bavi,et al.  Exploration of Novel Inhibitors for Bruton’s Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation , 2016, PloS one.

[21]  A. Masunov,et al.  Molecular dynamic simulation of wild type and mutants of the polymorphic amyloid NNQNTF segments of elk prion: structural stability and thermodynamic of association. , 2011, Biopolymers.

[22]  A. Khokhlov,et al.  Solvent accessible surface area of amino acid residues in globular proteins: correlation of apparent transfer free energies with experimental hydrophobicity scales. , 2009, Biomacromolecules.

[23]  S. Harrison,et al.  Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.

[24]  Chengsheng Zhang,et al.  Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2 , 2005, The EMBO journal.

[25]  J. Skolnick,et al.  What is the probability of a chance prediction of a protein structure with an rmsd of 6 A? , 1998, Folding & design.

[26]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.